SpyGlass Pharma reports 4-year glaucoma implant trial data
Go back to SpyGlass Pharma reports 4-year glaucoma implant trial data| SCHERING-PLOUGH CORPORATION (NASDAQ: SGP) | Delayed: 28.07 +0.36 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.71 | 52 Week High | $29.75 | |||
| Open | $27.43 | 52 Week Low | $15.27 | |||
| Day High | $28.30 | P/E | 18.59 | |||
| Day Low | $27.33 | EPS | $1.51 | |||
| Volume | 66,896 | |||||



